Hemo Organic Limited (HEMORGANIC) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Hemo Organic Limited stock ₹17.93, price ₹19.95, that is 10.1% below the price, quality 24 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Hemo Organic Limited
HEMORGANIC · BSEExpensive (fair value 10% below the price) and weak company, but rising price: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 15, 2026.
How to read this chart
60‑month range ₹5.86 – ₹77.15 · fair‑value band ₹13.45 – ₹22.41 · the ₹19.95 price screens above the ₹17.93 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 15, 2026.
Every Wednesday you see whether Hemo Organic is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Hemo Organic Limited engages in the manufacture and sale of ayurvedik or Unani pharmaceutical preparations in India. It also engages in the manufacturing, trading, and dealing of chemicals, dyes, pigments, auxiliaries, intermediates, heavy and fine chemicals, organic and inorganic chemicals, etc.
Show moreShow less
The company was formerly known as Dinesh Allorga Limited and changed its name to Hemo Organic Limited in August 2013. The company was incorporated in 1992 and is based in Anand, India.
Stock analysis
Hemo Organic Limited (HEMORGANIC) currently trades at ₹19.95, while our estimate is ₹17.93, 10% below the price, so the stock looks overvalued today.
Show more
Valuation
None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: ₹13.45 (bear) to ₹22.41 (bull), the price of ₹19.95 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 24/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Hemo Organic Limited reported revenue of ₹9.3M in FY2026 versus ₹68.3K in FY2022, a compound +241.5%/yr. Reported net income was −₹7.8M in FY2026.
Key figures
Market cap ₹137M (≈ $1.5M) Micro · P/S ratio 6.11 · EPS (TTM) ₹−2.10 · Net margin −31.0% · Return on equity −49.0% · Return on assets (EBIT) −15.4% (5-year average) · Operating margin −17.4% · Revenue (TTM) ₹23.6M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 5 out of 100 (low confidence).
What moves the price
The share trades about 18% below its 52-week high and 95% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −27% fair-value upside, at −10%, HEMORGANIC screens cheaper than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
HEMORGANIC screens overvalued: fair value 10% below the price. Compare with Merck KGaA →
Compare Hemo Organic Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 607 stocks
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- P/E, EV/EBITDA and margins by industry (reference tables)
- Return on equity by industry
- Quality Score by industry
- PEG screener for stocks with fair value
- Undervalued stocks: Healthcare
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Zoetis Inc ZTS | $83.48 | $113.53 | +36% | vs HEMORGANIC |
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥46.90 | ¥52.43 | +12% | vs HEMORGANIC |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,872 | ₹1,983 | +6% | vs HEMORGANIC |
| Haleon plc HLN | $9.05 | $8.47 | −6% | vs HEMORGANIC |
| Merck KGaA MRK | €149.50 | €108.83 | −27% | vs HEMORGANIC |
| Galderma Group GALD | CHF 187.55 | CHF 112.46 | −40% | vs HEMORGANIC |
| Takeda Pharmaceutical Company TAK | $21.64 | $11.23 | −48% | vs HEMORGANIC |
| Sandoz Group SDZ | CHF 81.50 | CHF 40.91 | −50% | vs HEMORGANIC |
| Teva Pharmaceutical Industries Limited TEVA | $42.62 | $20.74 | −51% | vs HEMORGANIC |
| Divi's Laboratories Limited DIVISLAB | ₹11,049 | ₹1,567 | −86% | vs HEMORGANIC |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Hemo Organic Limited (HEMORGANIC) overvalued or undervalued?
What is the fair value of HEMORGANIC?
What is the quality score of HEMORGANIC?
What is the price target for Hemo Organic Limited (HEMORGANIC)?
What is the Hemo Organic Limited stock forecast for 2026?
What is the revenue of Hemo Organic Limited (HEMORGANIC)?
What is the intrinsic value of Hemo Organic Limited (HEMORGANIC)?
Is Hemo Organic Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of HEMORGANIC?
How much is Hemo Organic Limited worth?
What do the bullish and bearish scenarios say about HEMORGANIC?
How solid is the balance sheet of Hemo Organic Limited (HEMORGANIC)?
How far is HEMORGANIC from its 52-week high?
Which stocks are comparable to Hemo Organic Limited?
Is Hemo Organic Limited stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of Hemo Organic Limited (HEMORGANIC)?
What should I pay attention to with Hemo Organic Limited right now?
Key figures of Hemo Organic Limited
How large is the market capitalisation of Hemo Organic Limited (HEMORGANIC)?
What is the P/S ratio of Hemo Organic Limited (HEMORGANIC)?
What are the earnings per share of Hemo Organic Limited (HEMORGANIC)?
What is the net margin of Hemo Organic Limited (HEMORGANIC)?
What is the return on equity of Hemo Organic Limited (HEMORGANIC)?
What is the EBIT return on assets of Hemo Organic Limited (HEMORGANIC)?
What is the operating margin of Hemo Organic Limited (HEMORGANIC)?
How much free cash flow does Hemo Organic Limited (HEMORGANIC) generate?
How much net debt does Hemo Organic Limited (HEMORGANIC) carry?
Watch Hemo Organic Limited in the live analysis
One click puts Hemo Organic Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.